Assessment of CD19 exon 2 abundance as a proxy for CD19delta expression and prediction of anti-CD19 CAR therapy relapse

Research output: Contribution to conferencePosterResearchpeer-review

36 Downloads (Pure)
Original languageEnglish
Publication date2022
Publication statusPublished - 2022
Event10th Annual Immuno-Oncology Summit - Boston, United States
Duration: 12 Oct 202214 Oct 2022
Conference number: 10

Conference

Conference10th Annual Immuno-Oncology Summit
Number10
Country/TerritoryUnited States
CityBoston
Period12/10/202214/10/2022

Cite this